不完整流行病学数据下的推断:加拿大麻疹疫苗覆盖率概念验证研究
研究开发统计方法,利用高斯过程模型对加拿大各省份麻疹疫苗覆盖率缺失数据进行插补,构建按年龄和地区分层的完整模型数据集,并以英格兰较完整数据验证方法,用于支持麻疹疫情建模应对。
要点
- 加拿大各省麻疹疫苗覆盖率数据在剂次和年份上缺失较多,需统计插补。
- 采用高斯过程模型插补至少一剂麻疹疫苗的当前覆盖率。
- 建模框架用英格兰较完整数据验证,方法可扩展至其他疫苗可预防疾病。
核心结论
- 研究开发了在缺乏详细人群免疫数据时估计疫苗覆盖率的方法,可支持麻疹疫情建模应对,且方法可推广至其他疫苗可预防疾病。
研究设计与样本
- 研究从现有公开数据集和报告中整理加拿大各省份疫苗覆盖率标准化数据集,并采用高斯过程模型进行插补建模,以英格兰较完整数据验证建模框架。
主要发现
- 加拿大各省份疫苗覆盖率估计在地区、剂次和年份上存在大量缺失。
- 高斯过程模型可插补产生按省份和年龄分层的完整建模数据集。
- 建模框架在英格兰较完整数据上进行了验证。
临床怎么用
- 在麻疹疫情建模应对中,当人群免疫数据不完整时,可使用该插补方法估计按年龄和地区分层的疫苗覆盖率。
- 该方法及配套代码工具可应用于未来其他疫苗可预防疾病的疫情建模场景。
局限性
- 研究为概念验证,插补结果依赖现有公开数据的质量与可得性。
- 建模框架仅在英格兰较完整数据上验证,在加拿大的适用性仍需进一步评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS OF STUDY: Current measles outbreaks around the world have highlighted the evolving immunity landscape of some vaccine-preventable diseases (VPDs). In Canada, there have been approximately 1,100 reported measles cases between January and June 2026 alone. This far exceeds the previous average annual case counts of <200. This significant outbreak has underscored the need to better understand the present state of population immunity to measles in Canada, an essential input parameter for outbreak response models. Most population immunity in this setting is derived from routine childhood vaccination, but vaccine coverage data is available heterogeneously across the country and is typically collected cross-sectionally to monitor population adherence to immunization schedules rather than to inform population-level susceptibility. This study developed statistical methods to adapt available measles vaccine coverage estimates into more complete estimates of present-day immunity in Canada by age and province/territory (PT). METHODS & RESULTS: First, a standardized dataset for vaccine coverage by PT was collated from existing publicly-available datasets and reports. A significant number of vaccine coverage estimates were missing by PT, dose, and year. We used Gaussian Process models to impute current coverage with at least one dose of a measles vaccine, to create a complete 'modelled dataset' by PT and age. Our modelling framework was tested against data for England, which was much more complete, to validate our approach. IMPLICATIONS: We developed methodology for estimating vaccine coverage in the absence of detailed population immunity data, to support ongoing measles outbreak modelling response work. While this project focused on measles, we built the associated code/tools such that the methodology can be applied to other vaccine-preventable diseases in future outbreak settings.
引用
- Hadley L, Milwid RM, Hongoh V, et al. Making inferences with incomplete epidemiological data: a proof-of-concept estimating measles vaccine coverage across Canada. Vaccine. 2026. PMID: 42966042. doi:10.1016/j.vaccine.2026.129261
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。